Endo International | ENDP - Kapitał Własny I Rezerwy



Kapitał Własny I Rezerwy Zmiana Data
AbbVie USD -6.66B 3.39B 2026-03
Amarin USD 449.41M 9.87M 2026-03
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Coherus Biosciences USD 61.01M 26.76M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Heron Therapeutics USD 9.14M 4.15M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Ligand Pharmaceuticals USD 997.32M 19.89M 2026-03
Merck USD 45.88B 6.73B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.5B 436.7M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03
Zoetis USD 3.23B 98M 2026-03